A healthcare consulting service provider is looking for suppliers of Various Finished Dosage Formulations for commercial purposes. The suppliers must support this enquiry with BE study for oral formulations, zone IVb stability data and EUGMP.
1. Caspofungin (50 mg) Vials. The required quantity in the first year is 1,000 units, in the second year is 2,000 units and in the third year is 3,000 units. The packaging should be in box 1 vial.
2. Caspofungin (70 mg) Vials. The required quantity in the first year is 1,000 units, in the second year is 1,000 units and in the third year is 2,000 units. The packaging should be in box 1 vial.
3. Fluconazole (200 mg/ 100 ml) Oral Solution. The required quantity in the first year is 30,000 units, in the second year is 40,000 units and in the third year is 50,000 units. The packaging should be in box 1 bottle.
4. Levofloxacin (750 mg/ 150 ml) Oral Solution. The required quantity in the first year is 100,000 units, in the second year is 150,000 units and in the third year is 200,000 units. The packaging should be in box 1 bottle.
5. Vildagliptin (50 mg) + Metformin (500 mg) Tablets. The required quantity in the first year is 500,000 units, in the second year is 1,000,000 units and in the third year is 1,500,000 units. The packaging should be box 6 blisters x 10 tablets.
6. Vildagliptin (50 mg) + Metformin (850 mg) Tablets. The required quantity in the first year is 2,000,000 units, in the second year is 3,000,000 units and in the third year is 5,000,000 units. The packaging should be box 6 blisters x 10 tablets.
7. Vildagliptin (50 mg) + Metformin (1000 mg) Tablets. The required quantity in the first year is 2,000,000 units, in the second year is 3,000,000 units and in the third year is 5,000,000 units. The packaging should be box 6 blisters x 10 tablets.
09 Jun 2021